Form D · Biotechnology
Redbud Labs, Inc.
Chapel Hill, NC · CIK 0001705921
Offering snapshot reported Dec 20, 2018 · SEC filing
- Reported sold
- $305K Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2018 | Initial | $304,995 | No comparison | 7 | SEC filing |
| May 8, 2017 | Initial | $215,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-328534
Source: Form D, filed Dec 20, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard C. Spero | Director, Executive |
| Richard Superfine | Director |
| Kenneth P. West | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
120 E Cameron Ave 141 Phillips Hall Cb 3255
Chapel Hill, NC, 27599
Chapel Hill, NC, 27599